454 related articles for article (PubMed ID: 25800677)
1. Theophylline-nicotinamide cocrystal formation in physical mixture during storage.
Ervasti T; Aaltonen J; Ketolainen J
Int J Pharm; 2015; 486(1-2):121-30. PubMed ID: 25800677
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms by which moisture generates cocrystals.
Jayasankar A; Good DJ; Rodríguez-Hornedo N
Mol Pharm; 2007; 4(3):360-72. PubMed ID: 17488034
[TBL] [Abstract][Full Text] [Related]
3. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer.
Tomaszewska I; Karki S; Shur J; Price R; Fotaki N
Int J Pharm; 2013 Sep; 453(2):380-8. PubMed ID: 23727143
[TBL] [Abstract][Full Text] [Related]
4. Instability in theophylline and carbamazepine hydrate tablets: cocrystal formation due to release of lattice water.
Arora KK; Thakral S; Suryanarayanan R
Pharm Res; 2013 Jul; 30(7):1779-89. PubMed ID: 23568521
[TBL] [Abstract][Full Text] [Related]
5. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.
Seefeldt K; Miller J; Alvarez-Núñez F; Rodríguez-Hornedo N
J Pharm Sci; 2007 May; 96(5):1147-58. PubMed ID: 17455346
[TBL] [Abstract][Full Text] [Related]
6. Physical stability enhancement of theophylline via cocrystallization.
Trask AV; Motherwell WD; Jones W
Int J Pharm; 2006 Aug; 320(1-2):114-23. PubMed ID: 16769188
[TBL] [Abstract][Full Text] [Related]
7. Screening for pharmaceutical cocrystal hydrates via neat and liquid-assisted grinding.
Karki S; Friscić T; Jones W; Motherwell WD
Mol Pharm; 2007; 4(3):347-54. PubMed ID: 17497885
[TBL] [Abstract][Full Text] [Related]
8. Polymorphism and stability of ibuprofen/nicotinamide cocrystal: The effect of the crystalline synthesis method.
Guerain M; Guinet Y; Correia NT; Paccou L; Danède F; Hédoux A
Int J Pharm; 2020 Jun; 584():119454. PubMed ID: 32464230
[TBL] [Abstract][Full Text] [Related]
9. A New Ferulic Acid-Nicotinamide Cocrystal With Improved Solubility and Dissolution Performance.
Chaves Júnior JV; Dos Santos JAB; Lins TB; de Araújo Batista RS; de Lima Neto SA; de Santana Oliveira A; Nogueira FHA; Gomes APB; de Sousa DP; de Souza FS; Aragão CFS
J Pharm Sci; 2020 Mar; 109(3):1330-1337. PubMed ID: 31821823
[TBL] [Abstract][Full Text] [Related]
10. Polymorphism in anhydrous theophylline--implications on the dissolution rate of theophylline tablets.
Phadnis NV; Suryanarayanan R
J Pharm Sci; 1997 Nov; 86(11):1256-63. PubMed ID: 9383736
[TBL] [Abstract][Full Text] [Related]
11. Application of spray freeze drying to theophylline-oxalic acid cocrystal engineering for inhaled dry powder technology.
Tanaka R; Hattori Y; Otsuka M; Ashizawa K
Drug Dev Ind Pharm; 2020 Feb; 46(2):179-187. PubMed ID: 31937148
[TBL] [Abstract][Full Text] [Related]
12. Matrix-assisted cocrystallization (MAC) simultaneous production and formulation of pharmaceutical cocrystals by hot-melt extrusion.
Boksa K; Otte A; Pinal R
J Pharm Sci; 2014 Sep; 103(9):2904-2910. PubMed ID: 24807421
[TBL] [Abstract][Full Text] [Related]
13. Indomethacin-saccharin cocrystal: design, synthesis and preliminary pharmaceutical characterization.
Basavoju S; Boström D; Velaga SP
Pharm Res; 2008 Mar; 25(3):530-41. PubMed ID: 17703346
[TBL] [Abstract][Full Text] [Related]
14. Generation of 1:1 Carbamazepine:Nicotinamide cocrystals by spray drying.
Patil SP; Modi SR; Bansal AK
Eur J Pharm Sci; 2014 Oct; 62():251-7. PubMed ID: 24931188
[TBL] [Abstract][Full Text] [Related]
15. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API.
McNamara DP; Childs SL; Giordano J; Iarriccio A; Cassidy J; Shet MS; Mannion R; O'Donnell E; Park A
Pharm Res; 2006 Aug; 23(8):1888-97. PubMed ID: 16832611
[TBL] [Abstract][Full Text] [Related]
16. An investigation of indomethacin-nicotinamide cocrystal formation induced by thermal stress in the solid or liquid state.
Lin HL; Zhang GC; Huang YT; Lin SY
J Pharm Sci; 2014 Aug; 103(8):2386-95. PubMed ID: 24942554
[TBL] [Abstract][Full Text] [Related]
17. Detection of cocrystal formation based on binary phase diagrams using thermal analysis.
Yamashita H; Hirakura Y; Yuda M; Teramura T; Terada K
Pharm Res; 2013 Jan; 30(1):70-80. PubMed ID: 22907418
[TBL] [Abstract][Full Text] [Related]
18. Novel furosemide cocrystals and selection of high solubility drug forms.
Goud NR; Gangavaram S; Suresh K; Pal S; Manjunatha SG; Nambiar S; Nangia A
J Pharm Sci; 2012 Feb; 101(2):664-80. PubMed ID: 22081478
[TBL] [Abstract][Full Text] [Related]
19. In situ monitoring of carbamazepine-nicotinamide cocrystal intrinsic dissolution behaviour.
Qiao N; Wang K; Schlindwein W; Davies A; Li M
Eur J Pharm Biopharm; 2013 Apr; 83(3):415-26. PubMed ID: 23159709
[TBL] [Abstract][Full Text] [Related]
20. Cocrystal dissociation in the presence of water: a general approach for identifying stable cocrystal forms.
Eddleston MD; Madusanka N; Jones W
J Pharm Sci; 2014 Sep; 103(9):2865-2870. PubMed ID: 24824298
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
